Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dopamine Receptor Imaging to Predict Response to Stimulant Therapy in Chronic TBI

NCT02225106 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT02225106
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02225106 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dopamine Receptor Imaging to Predict Response to Stimulant Therapy in Chronic TBI
Lead sponsor
University of Pennsylvania
Phase
Phase 2
Overall status
Completed
Start date
August 6, 2014
Completion date
June 21, 2017
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

attention deficit disorder, cognition disorder, traumatic brain injury